JPMorgan Starts MAP Pharmaceuticals (MAPP) at Overweight
Tweet
Share
E-mailGet Alerts MAPP Hot Sheet
Price: $28.30 --0%
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 12 | New: 26
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 12 | New: 26
Join SI Premium – FREE
JPMorgan initiates coverage on MAP Pharmaceuticals (NASDAQ: MAPP) with an Overweight. PT $23.00.
For an analyst ratings summary and ratings history on MAP Pharmaceuticals click here. For more ratings news on MAP Pharmaceuticals click here.
Shares of MAP Pharmaceuticals closed at $13.44 yesterday.
For an analyst ratings summary and ratings history on MAP Pharmaceuticals click here. For more ratings news on MAP Pharmaceuticals click here.
Shares of MAP Pharmaceuticals closed at $13.44 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- B.Riley Starts Weave Communications Inc (WEAV) at Buy
- Barclays Starts Centrus Energy Corp. (LEU) at Equalweight
- Noble Capital Starts Xerox (XRX) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
